"The effect of 48-weeks azithromycin therapy on levels of soluble biomarkers associated with HIV-associated chronic lung disease".
Hameiri-Bowen D, Yindom LM, Sovershaeva E, Bandason T, Mayini J, M Rehman A, Simms V, Gift Ngwira L, Flagestad T, Jarl Gutteberg T, McHugh G, Abbas Ferrand R, Rowland-Jones SL.
Hameiri-Bowen D, et al. Among authors: yindom lm.
Int Immunopharmacol. 2023 Mar;116:109756. doi: 10.1016/j.intimp.2023.109756. Epub 2023 Jan 20.
Int Immunopharmacol. 2023.
PMID: 36682262
Free PMC article.
Clinical Trial.